Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 5,000 shares at $38.33 ($193K) on 2015-02-02, disclosed to the SEC on 2015-02-04.
Scheduled sale ($193k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.33 | 2,800 | $107K | 55.5% |
| 2 | $39.03 | 1,900 | $74K | 38.3% |
| 3 | $39.95 | 300 | $12K | 6.2% |
| Total | $38.69 avg | 5,000 | $193K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |